SCHEMBL7985490

SCHEMBL7985490

O=c1[nH]c(-c2ccccn2)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
KMT2A Q03164 2/20 0.55
HPGD P15428 1/20 0.53
HTT P42858 3/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
LMNA P02545 2/20 0.49
GAA P10253 1/20 0.49
HIF1A Q16665 1/20 0.49
BRD4 O60885 1/20 0.46
PNP P00491 2/20 0.44
PARN O95453 1/20 0.44
CNOT7 Q9UIV1 1/20 0.44
METAP2 P50579 2/20 0.43
METAP1 P53582 2/20 0.43
KRAS P01116 1/20 0.43
HSP90AA1 P07900 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974051 0.91 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KMT2AHPGDHTT
SCHEMBL7991530 0.91 HPGD (0.48) ALDH1A1SMN1; SMN2KMT2AHPGDHTT
SCHEMBL7992174 0.90 SMN1; SMN2 (0.48) ALDH1A1SMN1; SMN2KMT2AHPGDHTT
SCHEMBL7985285 0.88 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KMT2AHPGDHTT
SCHEMBL7991785 0.88 HPGD (0.46) ALDH1A1SMN1; SMN2KMT2AHPGDHTT
SCHEMBL7991655 0.88 HPGD (0.46) ALDH1A1SMN1; SMN2KMT2AHPGDHTT
SCHEMBL7974003 0.88 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2KMT2AHPGDHTT
SCHEMBL7988799 0.86 LMNA (0.54) ALDH1A1SMN1; SMN2KMT2AHPGDHTT
SCHEMBL7985453 0.86 GAA (0.52) ALDH1A1SMN1; SMN2KMT2AHPGDHTT
SCHEMBL7975265 0.85 SMN1; SMN2 (0.61) ALDH1A1SMN1; SMN2KMT2AHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed